Colgate-Palmolive is one of the leaders in the global toothpaste market. On January 31, Colgate-Palmolive released financial results that left me with mixed reactions. Demand for its products in Latin America is growing rapidly, but the strengthening of the US dollar has not allowed Colgate-Palmolive to fully reflect this in its EPS.
Colgate-Palmolive Company (NYSE:CL ) UBS Global Consumer and Retail Conference Call March 12, 2025 3:00 PM ET Company Participants John Faucher - Chief Investor Relations Officer and EVP, M&A Conference Call Participants Peter Grom - UBS Peter Grom All right. Good afternoon, everyone.
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
The stock market is selling off, with Canada and China retaliating against President Donald Trump's tariffs , and Mexico promising to announce its response on Sunday.
CL's strong pricing strategy, premium innovation and brand-building investments lay the foundation for long-term growth despite near-term challenges.
For the first time in nearly two years, the rate of consumer spending in the United States has posted a contraction, signaling a potential weakness wave brewing up for the consumer cyclical names in the stock market and the broader economy. While most investors would just let a piece of data like this fly over their portfolios, the ones that make the big money will realize what's at stake here.
Colgate-Palmolive Company (NYSE:CL ) Consumer Analyst Group of New York Conference (CAGNY) 2025 February 21, 2025 8:00 AM ET Company Participants Noel Wallace - Chairman, President and Chief Executive Officer Prabha Narasimhan - Executive VP & GM of India Conference Call Participants Bryan Spillane - Bank of America Dara Mohsenian - Morgan Stanley Bryan Spillane Good morning. It's Friday, day four, day four and a half I guess here at CAGNY.
Colgate-Palmolive plans to expand its pet nutrition portfolio with the acquisition of Prime100, reinforcing its commitment to premium, science-backed pet food.
CL faces near-term headwinds. But its strong pricing strategy, premium innovation and brand-building investments lay the foundation for long-term growth.
Colgate-Palmolive stock (NYSE: CL) recently reported its Q4 results, with revenues missing and earnings slightly ahead of the street estimates. The company reported revenue of $4.94 billion and adjusted earnings of $0.91 per share, compared to the consensus estimates of $4.99 billion and $0.89, respectively.
Colgate-Palmolive Company CL posted mixed results for the fourth quarter on Friday.
Shares of Colgate-Palmolive (CL -4.61%) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.